Your browser doesn't support javascript.
loading
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?
Coleman, Ruth L; Gray, Alastair M; Broedl Md, Uli C; Fitchett, David; George, Jyothis T; Woerle, Hans J; Zinman, Bernard; Holman, Rury R.
Afiliación
  • Coleman RL; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Gray AM; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Broedl Md UC; Global Therapeutic Area Metabolism, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
  • Fitchett D; St Michael's Hospital, Division of Cardiology, University of Toronto, Toronto, Ontario, Canada.
  • George JT; Boehringer Ingelheim International, Ingelheim, Germany.
  • Woerle HJ; Global Therapeutic Area Metabolism, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
  • Zinman B; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Holman RR; Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada.
Diabetes Obes Metab ; 22(7): 1151-1156, 2020 07.
Article en En | MEDLINE | ID: mdl-32115840
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido